Ali Behbahani
Affiliations
- Director at Crispr Therapeutics Ag (CRSP), 2023-06-09
- Director at Nkarta Inc. (NKTK), 2023-06-09
- Director at Cvrx Inc. (CVRX), 2023-06-07
- Director at Arcellx Inc. (ACLX), 2023-06-05
- Director at Black Diamond Therapeutics Inc. (BDTX), 2023-05-18
- Director at Oyster Point Pharma Inc. (OYST), 2023-01-04
- Large Shareholder at Akouos Inc. (AKUS), 2022-12-02
- Large Shareholder at Bright Health Group Inc. (BHG), 2022-10-19
- Director at Adaptimmune Therapeutics Plc (ADAP), 2022-07-01
- Large Shareholder, Director at Monte Rosa Therapeutics Inc. (GLUE), 2022-06-16
- Director at Minerva Surgical Inc (UTRS), 2022-06-14
- Large Shareholder, Director at Genocea Biosciences Inc. (GNCA), 2022-05-26
- Large Shareholder at Trevi Therapeutics Inc. (TRVI), 2022-04-13
- Large Shareholder at Metacrine Inc. (MTCR), 2021-12-27
- Large Shareholder at Marker Therapeutics Inc. (MRKR), 2021-03-18
- Other at Regulus Therapeutics Inc. (RGLS), 2021-03-17
- Large Shareholder at Savara Inc (SVRA), 2021-03-16
- Large Shareholder at Mirum Pharmaceuticals Inc. (MIRM), 2019-07-24
- Large Shareholder at Arsanis Inc. (ASNS), 2018-07-17
- Director at Nevro Corp (NVRO), 2018-05-24
Insider Trading: Purchases See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| TRVI | $1.90 | 948,948 | Large Shareholder | 948,948 | 2022-04-11 | Filing | |
| TRVI | $1.90 | 2,631,578 | Large Shareholder | 10,421,428 | 2022-04-11 | Filing | |
| TRVI | $0.00 | 1,851,852 | Large Shareholder | 7,789,850 | 2021-10-18 | Filing | |
| GLUE | $19.00 | 1,050,000 | Large Shareholder, Director | 7,692,298 | 2021-06-28 | Filing | |
| MRKR | $1.75 | 5,714,285 | Large Shareholder | 10,714,285 | 2021-03-16 | Filing |
Insider Trading: Sales See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| GNCA | $0.08 | 4,445,093 | Large Shareholder, Director | 0 | 2022-05-25 | Filing | |
| GNCA | $0.07 | 5,931,843 | Large Shareholder, Director | 4,445,093 | 2022-05-24 | Filing | |
| MTCR | $0.91 | 170,932 | Large Shareholder | 2,563,257 | 2021-12-22 | Filing | |
| MTCR | $1.00 | 288,768 | Large Shareholder | 2,734,189 | 2021-12-22 | Filing | |
| MTCR | $1.32 | 37,570 | Large Shareholder | 3,022,957 | 2021-12-10 | Filing |